3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Conditions
Multiple Myeloma
2
Hematologic Neoplasms
2
Leukemia, Plasma Cell
1
Infections
1
Immunoglobulin Light-chain Amyloidosis
1
Interventions
Peripheral Blood Stem Cell Transplantation
10
Cyclophosphamide
8
fludarabine phosphate
7
Whole-Body Irradiation
6
Mycophenolic Acid
6
Cyclosporine
5
Radiotherapy
4
Melphalan
4
Filgrastim
4
Carboplatin
4
Busulfan
4
Tacrolimus
3
Etoposide
3
Epoetin Alfa
3
Darbepoetin alfa
3
sargramostim
2
liposomal amphotericin B
2
Thiotepa
2
Therapeutics
2
Morphine
2
Methylprednisolone
2
Interferon-alpha
2
Fentanyl
2
Early Intervention, Educational
2
Caspofungin
2
Carmustine
2
Antilymphocyte Serum
2
talquetamab
1
pyroxamide
1
nelarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Immunoglobulin Light-chain Amyloidosis
×
talquetamab
×
Other hematologic neoplasm
×
Clear all
NCT06855121
2025-03-03
NIMMS
St. Olavs Hospital
Recruiting
400 enrolled